Abstract
Introduction The debut of ChatGPT on 30 November 2022, marked a new era in artificial intelligence (AI) innovation, ushering transformative progress in science and research efficiency. Yet, AI’s exact influence on scientific and biomedical literature remains unclear. Words like “delve”, “realm” and “underscore” are linked with AI chatbots rather than human authors, potentially signalling AI utilisation.
Methods An extensive search of the electronic databases PubMed and Scopus was conducted, spanning from their inception to 28 May 2024, covering a period of 175 years from 1849 to 2024. The search identified occurrences of the words “delve”, “realm” and “underscore” individually and in various combinations within the scientific literature.
Results Between 1849 and 2024, the simultaneous occurrence of “delve”, “realm” and “underscore” was observed exclusively during 2023 and 2024. Notably, in 2023 and 2024, “delve” and “underscore”, appeared together in 1,284 out of 1,299 (98.8%) PubMed articles (p-value = 0.0002) and 546 out of 566 (96.5%) Scopus articles (p-value= 0.0006) where they were used since 1849. The co-usage of these words increased by up to 85-fold in 2023 and 2024 compared to 2022 and prior years.
Additionally, among articles since 1849, in 2023 and 2024, “delve” appeared in 7,714 out of 17,537 (44.0%) PubMed and 6,360 out of 13,707 (46.4%) Scopus articles, “realm” in 3,825 out of 16,288 (23.5%) PubMed and 16,360 out of 82,714 (19.8%) Scopus articles, and “underscore” in 27,653 out of 95,606 (28.9%) PubMed and 39,154 out of 111,803 (35.0%) Scopus articles.
Conclusion The analysis reveals a surge in the use of “delve”, “realm” and “underscore”—words presently associated with AI chatbots—during 2023 and 2024, highlighting the growing influence of AI chatbots like ChatGPT, introduced in November 2022, on academic writing. This trend highlights the increasing integration of AI-generated text in scientific articles, prompting further exploration into broader implications on research practices and scholarly communication.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
No funding was received for this work.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines, such as any relevant EQUATOR Network research reporting checklist(s) and other pertinent material, if applicable.
Yes
Data Availability
All data produced in the present work are contained in the manuscript
